Mitch Dowsett

Microarray-Based Class Discovery for Molecular Classification of Breast Cancer: Analysis of Interobserver Agreement

Jorge S. Reis-Filho, Alan Mackay, Alan Ashworth, 2011, Journal of the National Cancer Institute.

Small Molecule Inhibition of MERTK Is Efficacious in Non–Small Cell Lung Cancer Models Independent of Driver Oncogene Status

S. Frye, B. Hendriks, P. Harari, 2015, Molecular Cancer Therapeutics.

Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC).

M. Dowsett, I. Smith, R. A’Hern, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Expression of epidermal growth factor receptor and c-erbB2 during the development of tamoxifen resistance in human breast cancer.

M. Dowsett, S. Johnston, I. Smith, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer

M. Dowsett, J. Reis-Filho, Z. Ghazoui, 2015, Breast Cancer Research.

An in vitro model showing adaptation to long-term oestrogen deprivation highlights the clinical potential for targeting kinase pathways in combination with aromatase inhibition

S. Johnston, Z. Ghazoui, S. Pancholi, 2011, Steroids.

High incidence of HER-2 positivity in inflammatory breast cancer.

M. Dowsett, I. Smith, M. Hills, 2004, Breast.